Osaic Holdings’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3K | Sell |
26,558
-38,500
| -59% | -$20.8K | ﹤0.01% | 5539 |
|
|
2025
Q1 | $13K | Buy |
65,058
+38,500
| +145% | +$7.7K | ﹤0.01% | 5594 |
|
|
2024
Q4 | $14.3K | Buy |
26,558
+11,300
| +74% | +$6.1K | ﹤0.01% | 5518 |
|
|
2024
Q3 | $14.5K | Hold |
15,258
| – | – | ﹤0.01% | 5514 |
|
|
2024
Q2 | $14.8K | Sell |
15,258
-4,000
| -21% | -$3.88K | ﹤0.01% | 5491 |
|
|
2024
Q1 | $30.4K | Buy |
19,258
+13,000
| +208% | +$20.5K | ﹤0.01% | 5064 |
|
|
2023
Q4 | $4.96K | Sell |
6,258
-4,200
| -40% | -$3.33K | ﹤0.01% | 6104 |
|
|
2023
Q3 | $8.16K | Buy |
10,458
+8,200
| +363% | +$6.4K | ﹤0.01% | 5989 |
|
|
2023
Q2 | $2.09K | Buy |
2,258
+1,058
| +88% | +$978 | ﹤0.01% | 6535 |
|
|
2023
Q1 | $1.31K | Hold |
1,200
| – | – | ﹤0.01% | 6755 |
|
|
2022
Q4 | $2K | Sell |
1,200
-50
| -4% | -$83 | ﹤0.01% | 6548 |
|
|
2022
Q3 | $1K | Hold |
1,250
| – | – | ﹤0.01% | 6835 |
|
|
2022
Q2 | $2K | Hold |
1,250
| – | – | ﹤0.01% | 6771 |
|
|
2022
Q1 | $2K | Hold |
1,250
| – | – | ﹤0.01% | 6699 |
|
|
2021
Q4 | $5K | Buy |
1,250
+200
| +19% | +$800 | ﹤0.01% | 6507 |
|
|
2021
Q3 | $5K | Buy |
1,050
+1,000
| +2,000% | +$4.76K | ﹤0.01% | 6481 |
|
|
2021
Q2 | $0 | Buy |
+50
| New | – | ﹤0.01% | 6905 |
|
|
2020
Q4 | – | Sell |
-12,676
| Closed | -$101K | – | 6251 |
|
|
2020
Q3 | $101K | Buy |
+12,676
| New | +$101K | ﹤0.01% | 3821 |
|
|
2020
Q2 | – | Sell |
-1,000
| Closed | -$3K | – | 5975 |
|
|
2020
Q1 | $3K | Buy |
+1,000
| New | +$3K | ﹤0.01% | 5436 |
|